Tamarind Health has acquired TalkMED, expanding its integrated oncology platform and enhancing cancer care standards across Asia.

Information on the Target

Tamarind Health, a key player in the healthcare sector, is an integrated oncology-focused platform that is part of the Templewater portfolio. Following its acquisition of TalkMED in September 2025, Tamarind Health is poised for significant growth as it aims to elevate cancer care across Asia. This doctor-led initiative prioritizes patient well-being by consolidating leading medical practices under a unified umbrella, ensuring that the patients receive comprehensive healthcare services.

The foundational vision of Tamarind Health was established by distinguished specialists, particularly Dr. Miah Hiang Tay and Dr. Peter Ang, co-founders of OncoCare Singapore. Their practice has set a high standard for cancer care, serving as a model for Tamarind’s regional expansion. The addition of TalkMED, led by Dr. Peng Tiam Ang, further solidifies the firm's commitment to improving oncology standards for patients throughout the Asia region.

Industry Overview in the Target’s Specific Country

The healthcare industry in Asia, particularly in oncology, is experiencing significant challenges and opportunities. With a notable increase in cancer incidences across the region, there is